EDGAR Filing Documents for 0001193125-24-049260

Form 8-K - Current report:

SEC Accession No. 0001193125-24-049260

Filing Date

2024-02-28

Accepted

2024-02-28 08:08:30

Documents

Period of Report

2024-02-23

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d754681d8k.htm iXBRL	8-K	47681
2	EX-4.1	d754681dex41.htm	EX-4.1	72648
3	EX-10.1	d754681dex101.htm	EX-10.1	168265
4	EX-10.2	d754681dex102.htm	EX-10.2	73063
5	EX-10.3	d754681dex103.htm	EX-10.3	20273
6	EX-10.4	d754681dex104.htm	EX-10.4	21590
7	EX-10.5	d754681dex105.htm	EX-10.5	23189
8	EX-99.1	d754681dex991.htm	EX-99.1	11156
	Complete submission text file	0001193125-24-049260.txt		682831

Data Files

Seq	Description	Document	Type	Size
9	XBRL TAXONOMY EXTENSION SCHEMA	vtvt-20240223.xsd	EX-101.SCH	2862
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	vtvt-20240223_lab.xml	EX-101.LAB	17994
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	vtvt-20240223_pre.xml	EX-101.PRE	11269
23	EXTRACTED XBRL INSTANCE DOCUMENT	d754681d8k_htm.xml	XML	3685

Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265

Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300

vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)